tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with nomifensine in 1 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (nomifensine) | Trials (nomifensine) | Recent Studies (post-2010) (nomifensine) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 1,127 | 111 | 65 |
| Protein | Taxonomy | tyrosyl-arginyl-phenylalanyl-lysinamide (IC50) | nomifensine (IC50) |
|---|---|---|---|
| D | Rattus norvegicus (Norway rat) | 2.724 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1642 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 8.7096 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 3.115 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.0316 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0781 | |
| Transporter | Rattus norvegicus (Norway rat) | 2.7033 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudernatsch, MB; Schlösser, B; Sutor, B; ten Bruggencate, G | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and nomifensine
| Article | Year |
|---|---|
Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Dopamine; Dopamine Uptake Inhibitors; Electric Stimulation; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; In Vitro Techniques; Male; Neostriatum; Nomifensine; Oligopeptides; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1995 |